According to the 2021 China IP Awards, AFD China, by virtue of its outstanding expertise in pharma and biotech IP matters as well as its comprehensive and one-stop services offered to clients of the areas, was once again honored by Asia IP as "Pharma, Biotech & Life Sciences Firms of the Year".
In addition, our firm was also given the honor "Patent Litigation Firms of the Year" for the first time, which is a great recognition of our persistent efforts in fighting for the clients' rights and interests in legal proceedings. One of the administrative lawsuits that we assisted has been selected into the Essentials of Judgment of Intellectual Property Court of Supreme People's Court (2020).